TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET 42
1.4 LIMITATIONS 44
1.5 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 CURRENCY AND PRICING 49
2.5 DBMR TRIPOD DATA VALIDATION MODEL 50
2.6 MULTIVARIATE MODELLING 53
2.7 PRODUCT LIFELINE CURVE 53
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.9 DBMR MARKET POSITION GRID 55
2.10 MARKET END USERS COVERAGE GRID 56
2.11 VENDOR SHARE ANALYSIS 57
2.12 SECONDARY SOURCES 58
2.13 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 VALUE CHAIN ANALYSIS 62
4.2 SUPPLY CHAIN ANALYSIS 63
4.2.1 RAW MATERIAL PROCUREMENT 63
4.2.2 MANUFACTURING AND DISTRIBUTION 63
4.2.3 END USERS 63
4.3 PORTER'S FIVE FORCES 64
4.3.1 BARGAINING POWER OF SUPPLIERS 64
4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 64
4.3.3 THREAT OF NEW ENTRANTS 65
4.3.4 THREAT OF SUBSTITUTES PRODUCTS 65
4.3.5 INTENSITY OF COMPETITIVE RIVALRY 65
4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 66
4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 67
4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 68
4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 69
5 PRICING ANALYSIS 70
6 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 71
7 MARKET OVERVIEW, NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET 73
7.1 DRIVERS 75
7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 75
7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 75
7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 76
7.2 RESTRAINTS 76
7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 76
7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 77
7.3 OPPORTUNITIES 77
7.3.1 GROWING COMMERCIAL APPLICATION 77
7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 77
7.4 CHALLENGES 78
7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 78
7.4.2 PRODUCT LABELLING AND TRADE ISSUES 78
8 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 79
8.1 OVERVIEW 80
8.1.1 BACTERIA BASED 83
8.1.1.1 BACILLUS 84
8.1.1.1.1 SUBTILIS 85
8.1.1.1.2 LICHENIFORMIS 85
8.1.1.1.3 AMYLOLIQUEFACIENS 85
8.1.1.1.4 MEGATERIUM 85
8.1.1.1.5 MESENTRICUS 85
8.1.1.1.6 POLYMYXA 85
8.1.1.1.7 TOYONENSIS 85
8.1.1.1.8 OTHERS 85
8.1.1.2 LACTOBACILLUS 86
8.1.1.2.1 ACIDOPHILUS 86
8.1.1.2.2 BULGARICUS 86
8.1.1.2.3 REUTERI 86
8.1.1.2.4 CASEI 87
8.1.1.2.5 LACTIS 87
8.1.1.2.6 SALIVARIUS 87
8.1.1.2.7 PLANTARUM 87
8.1.1.2.8 RHAMNOSUS 87
8.1.1.2.9 FERMENTUM 87
8.1.1.2.10 FARCIMINIS 87
8.1.1.2.11 THERMOPHILUS 87
8.1.1.2.12 OTHERS 88
8.1.1.3 BIFIDOBACTERIUM 88
8.1.1.3.1 BIFIDIUM 88
8.1.1.3.2 BIFIDUS 88
8.1.1.3.3 THERMOPHILUS 88
8.1.1.3.4 ANIMALS 88
8.1.1.3.5 OTHERS 89
8.1.1.4 ENTEROCOCCUS 89
8.1.1.5 STREPTOCOCCUS 89
8.1.1.6 CLOSTRIDIUM 89
8.1.1.7 PEDIOCOCCUS 89
8.1.1.7.1 PARVULUS 89
8.1.1.7.2 ACIDILACTICI 89
8.1.1.7.3 OTHERS 90
8.1.2 FUNGI AND YEAST BASED 90
8.1.2.1 SACCHAROMYCES CEREVISIAE 91
8.1.2.2 SACCHAROMYCES BOULARDII 91
8.1.2.3 SACCHAROMYCES SERVISIA 91
8.1.2.4 CANDIDA 91
9 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 92
9.1 OVERVIEW 93
9.1.1 SINGLE STRAIN 96
9.1.2 MULTIPLE STRAIN 96
10 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 98
10.1 OVERVIEW 99
10.1.1 DRY 102
10.1.2 LIQUID 102
11 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 104
11.1 OVERVIEW 105
11.1.1 GUT HEALTH 108
11.1.2 IMMUNITY 108
11.1.3 NUTRITION 109
11.1.4 FEED INTAKE AND EFFICIENCY 110
11.1.5 YIELD 110
11.1.6 EGG PRODUCTION AND QUALITY 111
11.1.7 OTHERS 112
12 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 113
12.1 OVERVIEW 114
12.1.1 CHICKS AND POULTS 117
12.1.1.1 BACTERIA BASED 118
12.1.1.2 FUNGI AND YEAST BASED 118
12.1.2 BROILERS 118
12.1.2.1 BACTERIA BASED 119
12.1.2.2 FUNGI AND YEAST BASED 119
12.1.3 LAYERS 119
12.1.3.1 BACTERIA BASED 120
12.1.3.2 FUNGI AND YEAST BASED 120
12.1.4 BREEDERS 120
12.1.4.1 BACTERIA BASED 121
12.1.4.2 FUNGI AND YEAST BASED 121
12.1.5 OTHERS 121
13 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 122
13.1 NORTH AMERICA 123
13.1.1 U.S. 134
13.1.2 MEXICO 140
13.1.3 CANADA 146
14 NORTH AMERICA POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 152
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 152
15 SWOT ANALYSIS 153
16 COMPANY PROFILE 154
16.1 LALLEMAND INC 154
16.1.1 COMPANY SNAPSHOT 154
16.1.2 COMPANY SHARE ANALYSIS 154
16.1.3 PRODUCT PORTFOLIO 155
16.1.4 RECENT DEVELOPMENT 155
16.2 EVONIK INDUSTRIES AG 156
16.2.1 COMPANY SNAPSHOT 156
16.2.2 REVENUE ANALYSIS 156
16.2.3 COMPANY SHARE ANALYSIS 157
16.2.4 PRODUCT PORTFOLIO 157
16.2.5 RECENT DEVELOPMENT 157
16.3 ASAHI GROUP HOLDINGS, LTD 158
16.3.1 COMPANY SNAPSHOT 158
16.3.2 REVENUE ANALYSIS 158
16.3.3 COMPANY SHARE ANALYSIS 159
16.3.4 PRODUCT PORTFOLIO 159
16.3.5 RECENT DEVELOPMENT 159
16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 160
16.4.1 COMPANY SNAPSHOT 160
16.4.2 REVENUE ANALYSIS 160
16.4.3 COMPANY SHARE ANALYSIS 161
16.4.4 PRODUCT PORTFOLIO 161
16.4.5 RECENT DEVELOPMENT 161
16.5 PHILEO BY LESAFFRE 162
16.5.1 COMPANY SNAPSHOT 162
16.5.2 COMPANY SHARE ANALYSIS 162
16.5.3 PRODUCT PORTFOLIO 163
16.5.4 RECENT DEVELOPMENT 163
16.6 ADVANCED ENZYME TECHNOLOGIES 164
16.6.1 COMPANY SNAPSHOT 164
16.6.2 REVENUE ANALYSIS 164
16.6.3 PRODUCT PORTFOLIO 165
16.6.4 RECENT DEVELOPMENT 165
16.7 ALLTECH 166
16.7.1 COMPANY SNAPSHOT 166
16.7.2 PRODUCT PORTFOLIO 166
16.7.3 RECENT DEVELOPMENTS 166
16.8 BIOCAMP 167
16.8.1 COMPANY SNAPSHOT 167
16.8.2 PRODUCT PORTFOLIO 167
16.8.3 RECENT DEVELOPMENT 167
16.9 CHR. HANSEN HOLDING A/S 168
16.9.1 COMPANY SNAPSHOT 168
16.9.2 REVENUE ANALYSIS 168
16.9.3 PRODUCT PORTFOLIO 169
16.9.4 RECENT DEVELOPMENT 169
16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 170
16.10.1 COMPANY SNAPSHOT 170
16.10.2 PRODUCT PORTFOLIO 170
16.10.3 RECENT DEVELOPMENT 170
16.11 KEMIN INDUSTRIES, INC 171
16.11.1 COMPANY SNAPSHOT 171
16.11.2 PRODUCT PORTFOLIO 171
16.11.3 RECENT DEVELOPMENT 171
16.12 NOVOZYMES 172
16.12.1 COMPANY SNAPSHOT 172
16.12.2 REVENUE ANALYSIS 172
16.12.3 PRODUCT PORTFOLIO 173
16.12.4 RECENT DEVELOPMENT 173
16.13 PANGOO 174
16.13.1 COMPANY SNAPSHOT 174
16.13.2 PRODUCT PORTFOLIO 174
16.13.3 RECENT DEVELOPMENT 174
16.14 PROVITA ANIMAL HEALTH 175
16.14.1 COMPANY SNAPSHOT 175
16.14.2 PRODUCT PORTFOLIO 175
16.14.3 RECENT DEVELOPMENT 175
16.15 UNIQUE BIOTECH 176
16.15.1 COMPANY SNAPSHOT 176
16.15.2 PRODUCT PORTFOLIO 176
16.15.3 RECENT DEVELOPMENT 176
17 QUESTIONNAIRE 177
18 RELATED REPORTS 180

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.